Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 19, 2012

Drug Name	Review Type	Class	Manufacturer
Stribild	New Drug Initial Review	HIV	Gilead
Bydureon	New Drug Initial Review	Incretin Mimetics � GLP-1 Analog	Amylin
Qnasl	New Drug Appeal	Intranasal Steroid	Teva
Pradaxa	PDL Appeal	Direct Thrombin Inhibitor	Boehringer-Ingelheim

Footer